| PS test | Pancreozymin-Secretion test = combined secretin-CCK test |
|---|---|
| SCD | 1) Sickle Cell Disease 2) Subacute Combined Degeneration |
| SCID | Severe Combined Immuno-Deficiency; 중증 복합 면역 결핍증 |
| CAH | chronic active hepatitis; chronic aggressive hepatitis; combined atrial hypertrophy; congenital adre... |
| CCT | carotid compression tomography; central conduction time; cerebrocranial trauma; chocolate-coated tab... |
| EMLA | Eutectic Mixture of Local Anaesthetics |
|---|---|
| LA | Local anaesthetics |
| CSE | Combined Spinal-Epidural |
| CAB | Combined androgen blockade |
| CCT | Combined cortical thickness |
| anaesthetics, combined | The use of two or more chemicals simultaneously or sequentially to induce anaesthesia. The drugs need not be in the same dosage form. (12 Dec 1998) |
|---|
| anaesthetics | Agents that are capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general anaesthesia, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (12 Dec 1998) |
|---|---|
| anaesthetics, dissociative | Intravenous anaesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to neuroleptanalgesia, but is brought about by the administration of a single drug. (12 Dec 1998) |
| anaesthetics, general | Agents that induce various degrees of analgesia; depression of consciousness, circulation, and respiration; relaxation of skeletal muscle; reduction of reflex activity; and amnesia. There are two types of general anaesthetics, inhalation and intravenous. With either type, the arterial concentration of drug required to induce anaesthesia varies with the condition of the patient, the desired depth of anaesthesia, and the concomitant use of other drugs. (12 Dec 1998) |
| anaesthetics, inhalation | Gases or volatile liquids that vary in the rate at which they induce anaesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anaesthetics have advantages over intravenous agents in that the depth of anaesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (12 Dec 1998) |
| anaesthetics, intravenous | Ultrashort-acting anaesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (12 Dec 1998) |
| anaesthetics, local | Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fibre. In contact with a nerve trunk, these anaesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. Nearly all local anaesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. They are commonly used not only in the peripheral nervous system, but also for spinal anaesthesia. The many drugs that have local anaesthetic actions as a side effect but are not used for their local anaesthetic action are not included here. (12 Dec 1998) |
| local anaesthetics | Drugs used for the interruption of the nerve transmission of pain sensations. They act at the site of application to prevent perception of pain; examples include procaine and lidocaine. (05 Mar 2000) |
| antibiotics, combined | Combination of antibiotics used against difficult-to-treat infections. Antibiotic combinations have been used mainly to broaden the antibacterial spectrum and prevent development of resistance. In some instances these combinations have shown lower toxicity, but drug antagonism may be one of the problems encountered by their use. They may be given simultaneously or sequentially. The drugs need not be in the same dosage form. (12 Dec 1998) |
| antineoplastic agent, combined | The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. (12 Dec 1998) |
| vaccines, combined | Two or more vaccines in a single dosage form. (12 Dec 1998) |
| combined cycle | Two or more generation processes in series or in parallel, configured to optimise the energy output of the system. (05 Dec 1998) |
| combined-cycle power plant | The combination of a gas turbine and a steam turbine in an electric generation plant. The waste heat from the gas turbine provides the heat energy for the steam turbine. (05 Dec 1998) |
| combined fat-and carbohydrate-induced hyperlipaemia | Hyperlipoproteinaemia characterised by increased plasma levels of chylomicrons, VLDL, pre-beta-lipoproteins, and triglycerides, and slight rise of cholesterol on a normal diet, with beta-lipoproteins normal; may be accompanied by bouts of abdominal pain, hepatosplenomegaly, susceptibility to atherosclerosis, and abnormal glucose tolerance; probably autosomal recessive inheritance. Synonym: combined fat-and carbohydrate-induced hyperlipaemia, familial hyperchylomicronaemia with hyperprebetalipoproteinaemia, mixed hyperlipaemia. (05 Mar 2000) |
| combined glaucoma | Glaucoma with angle-closure and open-angle mechanisms in the same eye. (05 Mar 2000) |
| combined heat and power | An older term for what is now generally called cogeneration. The term is currently used in Europe and other foreign countries. (05 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|